semaglutide concerns misuse by untrained physicians a growing concern | Dr Rajiv Kumar Jain posted on the topic Concerns Surrounding Compounded GLP-1s Mount

Now their stomachs are paralyzed July 25, 2023 Facial lipoatrophy with semaglutide-related weight loss February 10, 2023 --------------------------------------- Glucagon-like peptide 1 (GLP-1) agonists are medications approved for treatment of diabetes that recently have also been used off label for weight loss.1 Studies have found increased risks of gastrointestinal adverse events (biliary disease,2 pancreatitis,3 bowel obstruction,4 and gastroparesis5) in patients with diabetes.2-5 Because such patients have higher baseline risk for gastrointestinal adverse events, risk in patients taking these drugs for other indications may differ

This information should be discussed with your provider to support a more informed decision about whether prescription-strength GLP-1 therapy aligns with your genetic and metabolic profile

Benefits of CoQ10

We listen to your history, understand your goals, and explain what's possible